Quantum Genomics S.A.S.
0D1J - LSE
Overview
Dividend safety
Dividends
Fundamentals
Add to watchlist
Add to calculator
Compare stock
Quantum Genomics S.A.S.
0D1J
-LSE
Overview
Create a free account to get access to stock details and our dividend tracker
We won't send you any spam and we don't want a credit card.
About stock
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure.
It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure.
Similar stocks
Based on sector and market capitalization
Report issue